Role of biomarkers in community-acquired pneumonia management

Basit Öğe Kaydı
dc.authorid0009-0008-0174-5801
dc.authorid0000-0001-9221-3692
dc.authorid0000-0001-6928-3633
dc.contributor.authorOnur, Bahaeddin
dc.contributor.authorDemirbas, Hakan Barış
dc.contributor.authorGülmez, Arif
dc.date.accessioned2024-08-02T12:53:38Z
dc.date.available2024-08-02T12:53:38Z
dc.date.issued2024
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Acil Tıp Ana Bilim Dalı
dc.description.abstractCommunity-acquired pneumonia (CAP) poses a significant global health threat, particularly affecting vulnerable populations. Biomarkers and scoring systems play a crucial role in diagnosing, assessing severity, and guiding treatment decisions for CAP patients. Biomarkers like C reactive protein, procalcitonin, and the neutrophil-to-lymphocyte ratio aid in diagnosis and severity assessment, while scoring systems such as CURB-65 and Pneumonia Severity Index classify patients into risk categories. Emerging biomarkers (uremia, elevated respiratory rate, hypotension, and age ≥ 65) like serum amyloid A and S100 proteins show promise in predicting disease severity and prognosis. However, further research is needed to determine their precise roles and clinical utility in CAP management.
dc.identifier.citationOnur, B., Demirbas, H. B., & Gülmez, A. (2024). Role of biomarkers in community-acquired pneumonia management. Journal of Acute Disease, 13(3), 87-92. https://doi.org/10.4103/jad.jad_65_24en_US
dc.identifier.doi10.4103/jad.jad_65_24
dc.identifier.endpage92
dc.identifier.issn2221-6189
dc.identifier.issn2589-5516
dc.identifier.issnhttps://doi.org/10.4103/jad.jad_65_24
dc.identifier.issue3
dc.identifier.scopusQ3en_US
dc.identifier.startpage87
dc.identifier.urihttps://hdl.handle.net/20.500.13055/742
dc.identifier.volume13
dc.identifier.wosWOS:001276798900005en_US
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynak.otherESCI - Emerging Sources Citation Index
dc.language.isoen
dc.publisherWolters Kluwer
dc.relation.ispartofJournal of Acute Disease
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCURB-65
dc.subjectCommunity-Acquired Pneumonia
dc.subjectProcalcitonin
dc.subjectAlpha-1 Antitrypsin
dc.subjectSerum Amyloid A
dc.titleRole of biomarkers in community-acquired pneumonia management
dc.typeReview Article
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
422.15 KB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Bölümü Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu